206 related articles for article (PubMed ID: 23891615)
1. Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model.
Paban V; Manrique C; Filali M; Maunoir-Regimbal S; Fauvelle F; Alescio-Lautier B
Neuropharmacology; 2014 Jan; 76 Pt A():68-79. PubMed ID: 23891615
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
3. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
[TBL] [Abstract][Full Text] [Related]
4. The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse.
Jeong EJ; Lee HK; Lee KY; Jeon BJ; Kim DH; Park JH; Song JH; Huh J; Lee JH; Sung SH
J Ethnopharmacol; 2013 Mar; 146(1):347-54. PubMed ID: 23333311
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
[TBL] [Abstract][Full Text] [Related]
6. Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease.
Nunes MA; Schöwe NM; Monteiro-Silva KC; Baraldi-Tornisielo T; Souza SI; Balthazar J; Albuquerque MS; Caetano AL; Viel TA; Buck HS
PLoS One; 2015; 10(11):e0142267. PubMed ID: 26605788
[TBL] [Abstract][Full Text] [Related]
7. Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice.
Ramalho RM; Nunes AF; Dias RB; Amaral JD; Lo AC; D'Hooge R; Sebastião AM; Rodrigues CM
Neurobiol Aging; 2013 Feb; 34(2):551-61. PubMed ID: 22621777
[TBL] [Abstract][Full Text] [Related]
8. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
9. Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.
Mori T; Koyama N; Segawa T; Maeda M; Maruyama N; Kinoshita N; Hou H; Tan J; Town T
J Biol Chem; 2014 Oct; 289(44):30303-30317. PubMed ID: 25157105
[TBL] [Abstract][Full Text] [Related]
10. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue improves streptozotocin-induced memory deficit by restoring mitochondrial function in rats.
Li L; Qin L; Lu HL; Li PJ; Song YJ; Yang RL
Brain Res; 2017 Feb; 1657():208-214. PubMed ID: 28034723
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
13. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease.
Jiang T; Yu JT; Zhu XC; Tan MS; Wang HF; Cao L; Zhang QQ; Shi JQ; Gao L; Qin H; Zhang YD; Tan L
Pharmacol Res; 2014 Mar; 81():54-63. PubMed ID: 24602800
[TBL] [Abstract][Full Text] [Related]
14. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
[TBL] [Abstract][Full Text] [Related]
15. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
16. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
17. Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase.
Atamna H; Kumar R
J Alzheimers Dis; 2010; 20 Suppl 2():S439-52. PubMed ID: 20463399
[TBL] [Abstract][Full Text] [Related]
18. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
[TBL] [Abstract][Full Text] [Related]
19. Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease.
Filali M; Lalonde R; Rivest S
Neuropharmacology; 2011 May; 60(6):930-6. PubMed ID: 21281652
[TBL] [Abstract][Full Text] [Related]
20. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
